Ola M Saad

Author PubWeight™ 8.14^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.	Nat Biotechnol	2012	2.43
2	Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry.	J Biol Chem	2005	1.21
3	Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.	Anal Biochem	2011	1.06
4	Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics.	Bioanalysis	2013	1.01
5	PK assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine.	Bioanalysis	2013	0.87
6	Potential inhibitors of chemokine function: analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry.	J Am Soc Mass Spectrom	2006	0.84
7	Semi-mechanistic Multiple-Analyte Pharmacokinetic Model for an Antibody-Drug-Conjugate in Cynomolgus Monkeys.	Pharm Res	2014	0.78